The global Kinetosis Drugs market was valued at US$ 394 million in 2023 and is anticipated to reach US$ 482 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.

Kinetosis Drugs Market

Kinetosis is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Kinetosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kinetosis Drugs.

Report Scope

The Kinetosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Kinetosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kinetosis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Kinetosis Drugs Market Report

Report Metric	Details
Report Name	Kinetosis Drugs Market
Accounted market size in 2023	US$ 394 million
Forecasted market size in 2030	US$ 482 million
CAGR	2.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Anticholinergic Antihistamines Others
Segment by Application	Adults Children
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GlaxoSmithKline, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, Viatris, Sandoz, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Kinetosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Kinetosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Kinetosis Drugs Market growing?

Ans: The Kinetosis Drugs Market witnessing a CAGR of 2.9% during the forecast period 2024-2030.

What is the Kinetosis Drugs Market size in 2030?

Ans: The Kinetosis Drugs Market size in 2030 will be US$ 482 million.

Who are the main players in the Kinetosis Drugs Market report?

Ans: The main players in the Kinetosis Drugs Market are GlaxoSmithKline, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, Viatris, Sandoz, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals

What are the Application segmentation covered in the Kinetosis Drugs Market report?

Ans: The Applications covered in the Kinetosis Drugs Market report are Adults, Children

What are the Type segmentation covered in the Kinetosis Drugs Market report?

Ans: The Types covered in the Kinetosis Drugs Market report are Anticholinergic, Antihistamines, Others

1 Kinetosis Drugs Market Overview

1.1 Product Overview and Scope of Kinetosis Drugs

1.2 Kinetosis Drugs Segment by Type

1.2.1 Global Kinetosis Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Anticholinergic

1.2.3 Antihistamines

1.2.4 Others

1.3 Kinetosis Drugs Segment by Application

1.3.1 Global Kinetosis Drugs Market Value by Application: (2024-2030)

1.3.2 Adults

1.3.3 Children

1.4 Global Kinetosis Drugs Market Size Estimates and Forecasts

1.4.1 Global Kinetosis Drugs Revenue 2019-2030

1.4.2 Global Kinetosis Drugs Sales 2019-2030

1.4.3 Global Kinetosis Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Kinetosis Drugs Market Competition by Manufacturers

2.1 Global Kinetosis Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Kinetosis Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Kinetosis Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Kinetosis Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Kinetosis Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Kinetosis Drugs, Product Type & Application

2.7 Kinetosis Drugs Market Competitive Situation and Trends

2.7.1 Kinetosis Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Kinetosis Drugs Players Market Share by Revenue

2.7.3 Global Kinetosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Kinetosis Drugs Retrospective Market Scenario by Region

3.1 Global Kinetosis Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Kinetosis Drugs Global Kinetosis Drugs Sales by Region: 2019-2030

3.2.1 Global Kinetosis Drugs Sales by Region: 2019-2024

3.2.2 Global Kinetosis Drugs Sales by Region: 2025-2030

3.3 Global Kinetosis Drugs Global Kinetosis Drugs Revenue by Region: 2019-2030

3.3.1 Global Kinetosis Drugs Revenue by Region: 2019-2024

3.3.2 Global Kinetosis Drugs Revenue by Region: 2025-2030

3.4 North America Kinetosis Drugs Market Facts & Figures by Country

3.4.1 North America Kinetosis Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Kinetosis Drugs Sales by Country (2019-2030)

3.4.3 North America Kinetosis Drugs Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Kinetosis Drugs Market Facts & Figures by Country

3.5.1 Europe Kinetosis Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Kinetosis Drugs Sales by Country (2019-2030)

3.5.3 Europe Kinetosis Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Kinetosis Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Kinetosis Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Kinetosis Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Kinetosis Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Kinetosis Drugs Market Facts & Figures by Country

3.7.1 Latin America Kinetosis Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Kinetosis Drugs Sales by Country (2019-2030)

3.7.3 Latin America Kinetosis Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Kinetosis Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Kinetosis Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Kinetosis Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Kinetosis Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Kinetosis Drugs Sales by Type (2019-2030)

4.1.1 Global Kinetosis Drugs Sales by Type (2019-2024)

4.1.2 Global Kinetosis Drugs Sales by Type (2025-2030)

4.1.3 Global Kinetosis Drugs Sales Market Share by Type (2019-2030)

4.2 Global Kinetosis Drugs Revenue by Type (2019-2030)

4.2.1 Global Kinetosis Drugs Revenue by Type (2019-2024)

4.2.2 Global Kinetosis Drugs Revenue by Type (2025-2030)

4.2.3 Global Kinetosis Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Kinetosis Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Kinetosis Drugs Sales by Application (2019-2030)

5.1.1 Global Kinetosis Drugs Sales by Application (2019-2024)

5.1.2 Global Kinetosis Drugs Sales by Application (2025-2030)

5.1.3 Global Kinetosis Drugs Sales Market Share by Application (2019-2030)

5.2 Global Kinetosis Drugs Revenue by Application (2019-2030)

5.2.1 Global Kinetosis Drugs Revenue by Application (2019-2024)

5.2.2 Global Kinetosis Drugs Revenue by Application (2025-2030)

5.2.3 Global Kinetosis Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Kinetosis Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 GlaxoSmithKline

6.1.1 GlaxoSmithKline Corporation Information

6.1.2 GlaxoSmithKline Description and Business Overview

6.1.3 GlaxoSmithKline Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 GlaxoSmithKline Kinetosis Drugs Product Portfolio

6.1.5 GlaxoSmithKline Recent Developments/Updates

6.2 Prestige Brands

6.2.1 Prestige Brands Corporation Information

6.2.2 Prestige Brands Description and Business Overview

6.2.3 Prestige Brands Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Prestige Brands Kinetosis Drugs Product Portfolio

6.2.5 Prestige Brands Recent Developments/Updates

6.3 WellSpring Pharmaceutical Corporation

6.3.1 WellSpring Pharmaceutical Corporation Corporation Information

6.3.2 WellSpring Pharmaceutical Corporation Description and Business Overview

6.3.3 WellSpring Pharmaceutical Corporation Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 WellSpring Pharmaceutical Corporation Kinetosis Drugs Product Portfolio

6.3.5 WellSpring Pharmaceutical Corporation Recent Developments/Updates

6.4 Baxter International

6.4.1 Baxter International Corporation Information

6.4.2 Baxter International Description and Business Overview

6.4.3 Baxter International Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Baxter International Kinetosis Drugs Product Portfolio

6.4.5 Baxter International Recent Developments/Updates

6.5 Viatris

6.5.1 Viatris Corporation Information

6.5.2 Viatris Description and Business Overview

6.5.3 Viatris Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Viatris Kinetosis Drugs Product Portfolio

6.5.5 Viatris Recent Developments/Updates

6.6 Sandoz

6.6.1 Sandoz Corporation Information

6.6.2 Sandoz Description and Business Overview

6.6.3 Sandoz Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Sandoz Kinetosis Drugs Product Portfolio

6.6.5 Sandoz Recent Developments/Updates

6.7 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer Kinetosis Drugs Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Myungmoon Pharm

6.8.1 Myungmoon Pharm Corporation Information

6.8.2 Myungmoon Pharm Description and Business Overview

6.8.3 Myungmoon Pharm Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Myungmoon Pharm Kinetosis Drugs Product Portfolio

6.8.5 Myungmoon Pharm Recent Developments/Updates

6.9 Caleb Pharmaceuticals

6.9.1 Caleb Pharmaceuticals Corporation Information

6.9.2 Caleb Pharmaceuticals Description and Business Overview

6.9.3 Caleb Pharmaceuticals Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Caleb Pharmaceuticals Kinetosis Drugs Product Portfolio

6.9.5 Caleb Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Kinetosis Drugs Industry Chain Analysis

7.2 Kinetosis Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Kinetosis Drugs Production Mode & Process

7.4 Kinetosis Drugs Sales and Marketing

7.4.1 Kinetosis Drugs Sales Channels

7.4.2 Kinetosis Drugs Distributors

7.5 Kinetosis Drugs Customers

8 Kinetosis Drugs Market Dynamics

8.1 Kinetosis Drugs Industry Trends

8.2 Kinetosis Drugs Market Drivers

8.3 Kinetosis Drugs Market Challenges

8.4 Kinetosis Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Prestige Brands

WellSpring Pharmaceutical Corporation

Caleb Pharmaceuticals

Viatris

List of Tables

Table 1. Global Kinetosis Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Kinetosis Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Kinetosis Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Kinetosis Drugs Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Kinetosis Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Kinetosis Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Kinetosis Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Kinetosis Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Kinetosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Kinetosis Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Kinetosis Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Kinetosis Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Kinetosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kinetosis Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Kinetosis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Kinetosis Drugs Sales by Region (2019-2024) & (Units)

Table 18. Global Kinetosis Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Kinetosis Drugs Sales by Region (2025-2030) & (Units)

Table 20. Global Kinetosis Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Kinetosis Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Kinetosis Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Kinetosis Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Kinetosis Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Kinetosis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Kinetosis Drugs Sales by Country (2019-2024) & (Units)

Table 27. North America Kinetosis Drugs Sales by Country (2025-2030) & (Units)

Table 28. North America Kinetosis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Kinetosis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Kinetosis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Kinetosis Drugs Sales by Country (2019-2024) & (Units)

Table 32. Europe Kinetosis Drugs Sales by Country (2025-2030) & (Units)

Table 33. Europe Kinetosis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Kinetosis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Kinetosis Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Kinetosis Drugs Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Kinetosis Drugs Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Kinetosis Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Kinetosis Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Kinetosis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Kinetosis Drugs Sales by Country (2019-2024) & (Units)

Table 42. Latin America Kinetosis Drugs Sales by Country (2025-2030) & (Units)

Table 43. Latin America Kinetosis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Kinetosis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Kinetosis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Kinetosis Drugs Sales by Country (2019-2024) & (Units)

Table 47. Middle East & Africa Kinetosis Drugs Sales by Country (2025-2030) & (Units)

Table 48. Middle East & Africa Kinetosis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Kinetosis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Kinetosis Drugs Sales (Units) by Type (2019-2024)

Table 51. Global Kinetosis Drugs Sales (Units) by Type (2025-2030)

Table 52. Global Kinetosis Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Kinetosis Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Kinetosis Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Kinetosis Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Kinetosis Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Kinetosis Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Kinetosis Drugs Price (USD/Unit) by Type (2019-2024)

Table 59. Global Kinetosis Drugs Price (USD/Unit) by Type (2025-2030)

Table 60. Global Kinetosis Drugs Sales (Units) by Application (2019-2024)

Table 61. Global Kinetosis Drugs Sales (Units) by Application (2025-2030)

Table 62. Global Kinetosis Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Kinetosis Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Kinetosis Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Kinetosis Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Kinetosis Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Kinetosis Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Kinetosis Drugs Price (USD/Unit) by Application (2019-2024)

Table 69. Global Kinetosis Drugs Price (USD/Unit) by Application (2025-2030)

Table 70. GlaxoSmithKline Corporation Information

Table 71. GlaxoSmithKline Description and Business Overview

Table 72. GlaxoSmithKline Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. GlaxoSmithKline Kinetosis Drugs Product

Table 74. GlaxoSmithKline Recent Developments/Updates

Table 75. Prestige Brands Corporation Information

Table 76. Prestige Brands Description and Business Overview

Table 77. Prestige Brands Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Prestige Brands Kinetosis Drugs Product

Table 79. Prestige Brands Recent Developments/Updates

Table 80. WellSpring Pharmaceutical Corporation Corporation Information

Table 81. WellSpring Pharmaceutical Corporation Description and Business Overview

Table 82. WellSpring Pharmaceutical Corporation Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. WellSpring Pharmaceutical Corporation Kinetosis Drugs Product

Table 84. WellSpring Pharmaceutical Corporation Recent Developments/Updates

Table 85. Baxter International Corporation Information

Table 86. Baxter International Description and Business Overview

Table 87. Baxter International Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Baxter International Kinetosis Drugs Product

Table 89. Baxter International Recent Developments/Updates

Table 90. Viatris Corporation Information

Table 91. Viatris Description and Business Overview

Table 92. Viatris Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Viatris Kinetosis Drugs Product

Table 94. Viatris Recent Developments/Updates

Table 95. Sandoz Corporation Information

Table 96. Sandoz Description and Business Overview

Table 97. Sandoz Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Sandoz Kinetosis Drugs Product

Table 99. Sandoz Recent Developments/Updates

Table 100. Pfizer Corporation Information

Table 101. Pfizer Description and Business Overview

Table 102. Pfizer Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Pfizer Kinetosis Drugs Product

Table 104. Pfizer Recent Developments/Updates

Table 105. Myungmoon Pharm Corporation Information

Table 106. Myungmoon Pharm Description and Business Overview

Table 107. Myungmoon Pharm Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Myungmoon Pharm Kinetosis Drugs Product

Table 109. Myungmoon Pharm Recent Developments/Updates

Table 110. Caleb Pharmaceuticals Corporation Information

Table 111. Caleb Pharmaceuticals Description and Business Overview

Table 112. Caleb Pharmaceuticals Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Caleb Pharmaceuticals Kinetosis Drugs Product

Table 114. Caleb Pharmaceuticals Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Kinetosis Drugs Distributors List

Table 118. Kinetosis Drugs Customers List

Table 119. Kinetosis Drugs Market Trends

Table 120. Kinetosis Drugs Market Drivers

Table 121. Kinetosis Drugs Market Challenges

Table 122. Kinetosis Drugs Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Kinetosis Drugs

Figure 2. Global Kinetosis Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Kinetosis Drugs Market Share by Type in 2023 & 2030

Figure 4. Anticholinergic Product Picture

Figure 5. Antihistamines Product Picture

Figure 6. Others Product Picture

Figure 7. Global Kinetosis Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Kinetosis Drugs Market Share by Application in 2023 & 2030

Figure 9. Adults

Figure 10. Children

Figure 11. Global Kinetosis Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Kinetosis Drugs Market Size (2019-2030) & (US$ Million)

Figure 13. Global Kinetosis Drugs Sales (2019-2030) & (Units)

Figure 14. Global Kinetosis Drugs Average Price (USD/Unit) & (2019-2030)

Figure 15. Kinetosis Drugs Report Years Considered

Figure 16. Kinetosis Drugs Sales Share by Manufacturers in 2023

Figure 17. Global Kinetosis Drugs Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Kinetosis Drugs Players: Market Share by Revenue in 2023

Figure 19. Kinetosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Kinetosis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Kinetosis Drugs Sales Market Share by Country (2019-2030)

Figure 22. North America Kinetosis Drugs Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Kinetosis Drugs Sales Market Share by Country (2019-2030)

Figure 26. Europe Kinetosis Drugs Revenue Market Share by Country (2019-2030)

Figure 27. Germany Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Kinetosis Drugs Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Kinetosis Drugs Revenue Market Share by Region (2019-2030)

Figure 34. China Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Kinetosis Drugs Sales Market Share by Country (2019-2030)

Figure 45. Latin America Kinetosis Drugs Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Kinetosis Drugs Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Kinetosis Drugs Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. U.A.E Kinetosis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Kinetosis Drugs by Type (2019-2030)

Figure 55. Global Revenue Market Share of Kinetosis Drugs by Type (2019-2030)

Figure 56. Global Kinetosis Drugs Price (USD/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Kinetosis Drugs by Application (2019-2030)

Figure 58. Global Revenue Market Share of Kinetosis Drugs by Application (2019-2030)

Figure 59. Global Kinetosis Drugs Price (USD/Unit) by Application (2019-2030)

Figure 60. Kinetosis Drugs Value Chain

Figure 61. Kinetosis Drugs Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions